{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T12:30:20Z","timestamp":1782304220331,"version":"3.54.5"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","croh-online.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.critrevonc.2015.10.014","type":"journal-article","created":{"date-parts":[[2015,11,7]],"date-time":"2015-11-07T21:16:20Z","timestamp":1446930980000},"page":"189-199","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Guidelines, \u201cminimal requirements\u201d and standard of care in glioblastoma around the Mediterranean Area: A report from the AROME (Association of Radiotherapy and Oncology of the Mediterranean arEa) Neuro-Oncology working party"],"prefix":"10.1016","volume":"98","author":[{"given":"Y.","family":"Belkacemi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bourdeaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Collin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Cornu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-Y.","family":"Delatre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Dhermain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Doz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-L.","family":"Habrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Hoang-Xuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Idbaih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Mammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Martin-Duverneuil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mokhtari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Roujeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Acharqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Atit Benali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Bakhti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Bena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bendjaafar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Benider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Bouaouina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Bounedjar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Boussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bouyoucef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Bouzid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Chougai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Daoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Errihani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Essoudaigui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Gachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Harif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Hilmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Hsissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Idali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Karkouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Kerboua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ouahabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sahraoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Harif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Sadki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Sami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Samlali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Terkmani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2015.10.014_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.critrevonc.2010.03.007","article-title":"Guidelines minimal requirements and standard of cancer care around the Mediterranean Area: report from the Collaborative AROME (Association of Radiotherapy and Oncology of the Mediterranean Area) working parties","volume":"78","author":"AROME (Association of Radiotherapy and Oncology of the Mediterranean Area)","year":"2011","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"10.1016\/j.critrevonc.2015.10.014_bib0010","first-page":"440","article-title":"Epidemiology of glioblastoma","volume":"56","author":"Badi","year":"2010","journal-title":"Neurochirurgie"},{"key":"10.1016\/j.critrevonc.2015.10.014_bib0015","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00401-009-0595-z","article-title":"Monoclonal antibody specific for IDH1 R132H mutation","volume":"118","author":"Capper","year":"2009","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.critrevonc.2015.10.014_bib0020","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1179\/1743132813Y.0000000260","article-title":"Factors associated with survival and recurrence for patients undergoing surgery of cerebellar metastases","volume":"36","author":"Chaichana","year":"2014","journal-title":"Neurol. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2015.10.014_bib0025","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1007\/s11060-014-1597-9","article-title":"The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors?","volume":"120","author":"Chaichana","year":"2014","journal-title":"J. Neurooncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2015.10.014_bib0030","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ijrobp.2006.12.009","article-title":"Evaluation of peritumoral edema in the delineation of radiotherapy clinical target volumes for glioblastoma","volume":"68","author":"Chang","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"3","key":"10.1016\/j.critrevonc.2015.10.014_bib0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/j.ijrobp.2007.03.061","article-title":"Phase I trial of gross total resection, permanent iodine-125 brachytherapy, and hyperfractionated radiotherapy for newly diagnosed glioblastoma multiforme","volume":"69","author":"Chen","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"10.1016\/j.critrevonc.2015.10.014_bib0040","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa1308345","article-title":"Bevacizumab plus radiotherapy-temozolomide for newly diagnosed glioblastoma","volume":"370","author":"Chinot","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2015.10.014_bib0045","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1634\/theoncologist.2009-0121","article-title":"FDA drug approval summary: bevacizumab (Avastin) as treatment of recurrent glioblastoma multiform","volume":"14","author":"Cohen","year":"2009","journal-title":"Oncologist"},{"key":"10.1016\/j.critrevonc.2015.10.014_bib0050","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1172\/JCI17669","article-title":"Expansion of human SCID-repopulating cells under hypoxic conditions","volume":"112","author":"Danet","year":"2003","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.critrevonc.2015.10.014_bib0055","doi-asserted-by":"crossref","first-page":"16","DOI":"10.5732\/cjc.013.10217","article-title":"Radiotherapy of high-grade gliomas: current standards and new concepts, innovations in imaging and radiotherapy, and new therapeutic approaches","volume":"33","author":"Dhermain","year":"2014","journal-title":"Chin. J. Cancer"},{"issue":"Suppl. 5","key":"10.1016\/j.critrevonc.2015.10.014_bib0060","doi-asserted-by":"crossref","first-page":"v1","DOI":"10.1093\/neuonc\/nos218","article-title":"CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2005\u20132009","volume":"14","author":"Dolecek","year":"2012","journal-title":"Neuro Oncol."},{"key":"10.1016\/j.critrevonc.2015.10.014_bib0065","doi-asserted-by":"crossref","first-page":"4033","DOI":"10.1200\/JCO.2007.11.3985","article-title":"Antiangiogenics the potential role of integrating this novel treatment modality with chemoradiation for solid cancers","volume":"26","author":"Duda","year":"2007","journal-title":"J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2015.10.014_bib0070","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/0360-3016(91)90171-Y","article-title":"Tolerance of normal tissue to therapeutic irradiation","volume":"21","author":"Emami","year":"1991","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.critrevonc.2015.10.014_bib0075","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.annpat.2012.09.228","article-title":"Guidelines for adult diffuse gliomas WHO grade II III and IV: pathology and biology. Soci\u00e9t\u00e9 francaise de neuropathologie. R\u00e9seau de neuro-oncologie pathologique","volume":"32","author":"Figarella-Branger","year":"2012","journal-title":"Ann. Pathol."},{"issue":"2","key":"10.1016\/j.critrevonc.2015.10.014_bib0080","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3171\/jns.1999.91.2.0251","article-title":"Accelerated fractionated proton\/photon irradiation to 90 cobalt gray equivalent forglioblastoma multiforme: results of a phase II prospective trial","volume":"91","author":"Fitzek","year":"1999","journal-title":"J. Neurosurg."},{"key":"10.1016\/j.critrevonc.2015.10.014_bib0085","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.critrevonc.2015.10.014_bib0090","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1038\/bjc.2011.153","article-title":"Implementation of neuro-oncology service reconfiguration in accordance with NICE guidance provides enhanced clinical care for patients with glioblastoma multiforme","volume":"104","author":"Guilfoyle","year":"2011","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.critrevonc.2015.10.014_bib0095","first-page":"240","article-title":"Phase II study of concurrent radiation therapy, temozolomide, and bevacizumab followed by bevacizumab\/everolimus as first-line treatment for patients with glioblastoma","volume":"l10","author":"Hainsworth","year":"2012","journal-title":"Clin. Adv. Hematol. Oncol."},{"issue":"9","key":"10.1016\/j.critrevonc.2015.10.014_bib0100","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1093\/jnen\/60.9.863","article-title":"Glioblastomas with an oligodendroglial component: a pathological and molecular study","volume":"60","author":"He","year":"2001","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"10","key":"10.1016\/j.critrevonc.2015.10.014_bib0105","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa043331","article-title":"MGMT gene silencing and benefit from temozolomide in glioblastoma","volume":"352","author":"Hegi","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2015.10.014_bib0110","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s11060-007-9426-z","article-title":"Delay in radiotherapy shortens survival in patients with high grade glioma","volume":"85","author":"Irwin","year":"2007","journal-title":"J. Neurooncol."},{"issue":"15","key":"10.1016\/j.critrevonc.2015.10.014_bib0115","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1212\/WNL.0b013e3181bc0184","article-title":"Patterns of relapse and prognosis after bevacizumab failure in recurrentglioblastoma","volume":"73","author":"Iwamoto","year":"2009","journal-title":"Neurology"},{"issue":"15","key":"10.1016\/j.critrevonc.2015.10.014_bib0120","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa065901","article-title":"Radiotherapy for glioblastoma in the elderly","volume":"356","author":"Keime-Guibert","year":"2007","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.critrevonc.2015.10.014_bib0125","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/S1470-2045(03)00970-7","article-title":"WHO's activities in the Eastern Mediterranean Region","volume":"4","author":"Khabir","year":"2003","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2015.10.014_bib0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-011-0589-2","article-title":"Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?","volume":"105","author":"Lawrence","year":"2011","journal-title":"J. Neurooncol."},{"issue":"17","key":"10.1016\/j.critrevonc.2015.10.014_bib0135","doi-asserted-by":"crossref","first-page":"4228","DOI":"10.1002\/cncr.26685","article-title":"Improving prognosis of glioblastoma in the 21st century: who has benefited most?","volume":"118","author":"Lawrence","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.critrevonc.2015.10.014_bib0140","series-title":"WHO Classification of Tumours of the Central Nervous System","author":"Louis","year":"2007"},{"issue":"9","key":"10.1016\/j.critrevonc.2015.10.014_bib0145","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S1470-2045(12)70265-6","article-title":"Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial","volume":"13","author":"Malmstr\u00f6m","year":"2015","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.critrevonc.2015.10.014_bib0150","unstructured":"NICE (2006) Service guidance for improving outcomes for people with brain and other central nervous system tumours. http:\/\/www.nice.org.uk\/nicemedia\/pdf\/CSG_brain_manual.pdf."},{"issue":"1","key":"10.1016\/j.critrevonc.2015.10.014_bib0155","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s11060-012-0883-7","article-title":"Waiting times before initiation of radiotherapy might not affect outcomes for patients with glioblastoma: a French retrospective analysis of patients treated in the era of concomitant temozolomide and radiotherapy","volume":"109","author":"Noel","year":"2012","journal-title":"J. Neurooncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2015.10.014_bib0160","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1158\/1078-0432.CCR-12-3002","article-title":"The definition of primary and secondary glioblastoma","volume":"19","author":"Ohgaki","year":"2013","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2015.10.014_bib0165","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am. J. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2015.10.014_bib0170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11060-009-9838-z","article-title":"Management of newly diagnosed glioblastoma: guidelines development, value and application","volume":"93","author":"Olson","year":"2009","journal-title":"J. Neurooncol."},{"issue":"Suppl. 1","key":"10.1016\/j.critrevonc.2015.10.014_bib0175","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1038\/sj.bjc.6604603","article-title":"Survival from brain tumours in England and Wales up to 2001","volume":"99","author":"Rachet","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"9830","key":"10.1016\/j.critrevonc.2015.10.014_bib0180","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1016\/S0140-6736(11)61346-9","article-title":"Primary brain tumours in adults","volume":"379","author":"Ricard","year":"2012","journal-title":"Rev. Lancet"},{"issue":"6","key":"10.1016\/j.critrevonc.2015.10.014_bib0185","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/j.1750-3639.2011.00491.x","article-title":"French brain tumor database: 5-year histological results on 25 756 cases","volume":"21","author":"Rigau","year":"2011","journal-title":"Brain Pathol."},{"issue":"9","key":"10.1016\/j.critrevonc.2015.10.014_bib0190","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1200\/JCO.2004.06.082","article-title":"Abbreviated course of radiation therapy in older patients with glioblastoma multiforme a prospective randomized clinical trial","volume":"22","author":"Roa","year":"2004","journal-title":"J. Clin. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2015.10.014_bib0195","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2015.10.014_bib0200","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12094-012-0916-x","article-title":"Impact og radiotherapydelay on survival in glioblastoma","volume":"15","author":"Valduvieco","year":"2013","journal-title":"Clin. Transl. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2015.10.014_bib0205","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S1470-2045(12)70164-X","article-title":"Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial","volume":"13","author":"Wick","year":"2012","journal-title":"Lancet Oncol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842815300640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1040842815300640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T19:21:36Z","timestamp":1537212096000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1040842815300640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":41,"alternative-id":["S1040842815300640"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2015.10.014","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guidelines, \u201cminimal requirements\u201d and standard of care in glioblastoma around the Mediterranean Area: A report from the AROME (Association of Radiotherapy and Oncology of the Mediterranean arEa) Neuro-Oncology working party","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2015.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}